DE69322872D1 - Vakzine gegen immunodefizienz-virus der katze (kiv) - Google Patents

Vakzine gegen immunodefizienz-virus der katze (kiv)

Info

Publication number
DE69322872D1
DE69322872D1 DE69322872T DE69322872T DE69322872D1 DE 69322872 D1 DE69322872 D1 DE 69322872D1 DE 69322872 T DE69322872 T DE 69322872T DE 69322872 T DE69322872 T DE 69322872T DE 69322872 D1 DE69322872 D1 DE 69322872D1
Authority
DE
Germany
Prior art keywords
kiv
cat
immunodeficiency virus
vaccine against
fiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69322872T
Other languages
English (en)
Other versions
DE69322872T2 (de
Inventor
Michael Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of DE69322872D1 publication Critical patent/DE69322872D1/de
Publication of DE69322872T2 publication Critical patent/DE69322872T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69322872T 1992-09-21 1993-09-20 Vakzine gegen immunodefizienz-virus der katze (kiv) Expired - Lifetime DE69322872T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929219936A GB9219936D0 (en) 1992-09-21 1992-09-21 Vaccines
PCT/GB1993/001974 WO1994006471A1 (en) 1992-09-21 1993-09-20 Anti-feline immunodeficiency virus (fiv) vaccines

Publications (2)

Publication Number Publication Date
DE69322872D1 true DE69322872D1 (de) 1999-02-11
DE69322872T2 DE69322872T2 (de) 1999-05-27

Family

ID=10722245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322872T Expired - Lifetime DE69322872T2 (de) 1992-09-21 1993-09-20 Vakzine gegen immunodefizienz-virus der katze (kiv)

Country Status (11)

Country Link
EP (1) EP0661999B1 (de)
JP (1) JP3604384B2 (de)
AT (1) ATE175119T1 (de)
AU (1) AU4826493A (de)
DE (1) DE69322872T2 (de)
DK (1) DK0661999T3 (de)
ES (1) ES2127294T3 (de)
GB (1) GB9219936D0 (de)
GR (1) GR3029264T3 (de)
WO (1) WO1994006471A1 (de)
ZA (1) ZA936970B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1679377A1 (de) * 1994-04-29 2006-07-12 Pharmacia & Upjohn Company LLC Impstoff gegen felines Immunodefizienz-Virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
DE69636440T4 (de) * 1995-08-25 2007-09-27 The Regents Of The University Of California, Oakland IL-2 unabhängige T-Zellen der Katze
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
GB9827077D0 (en) 1998-12-09 1999-02-03 Expro North Sea Ltd Improvements in or relating to well fluid sampling
WO2001004280A2 (de) * 1999-07-08 2001-01-18 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
FR2828687B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR2828686B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
EP1673633B9 (de) 2003-09-11 2011-03-02 Idexx Laboratories, Inc. Verfahren zum nachweis des felinen immunschwächevirus
US7285272B2 (en) 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1723425B1 (de) 2004-02-19 2011-04-06 Idexx Laboratories, Inc. Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
CA2576902C (en) 2004-06-30 2012-05-08 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス（ｆｉｖ）のｅｎｖタンパク質のｖ３領域に由来するペプチドの使用を含むｆｉｖを検出するための方法および装置
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (de) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Nachweis des felinen immundefizienzvirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) * 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins

Also Published As

Publication number Publication date
DK0661999T3 (da) 1999-08-30
JPH08504090A (ja) 1996-05-07
GB9219936D0 (en) 1992-11-04
EP0661999A1 (de) 1995-07-12
DE69322872T2 (de) 1999-05-27
ES2127294T3 (es) 1999-04-16
EP0661999B1 (de) 1998-12-30
AU4826493A (en) 1994-04-12
GR3029264T3 (en) 1999-05-28
WO1994006471A1 (en) 1994-03-31
ATE175119T1 (de) 1999-01-15
ZA936970B (en) 1994-08-29
JP3604384B2 (ja) 2004-12-22

Similar Documents

Publication Publication Date Title
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69636046D1 (de) Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ES2075040T3 (es) 2',3'-dideoxi-2',2'-difluoronucleosidos.
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
ATE241014T2 (de) Hiv-2 varianten
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
HUP0000432A2 (hu) Inzulin C-peptidek
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
PT996726E (pt) Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
CA2143187A1 (en) Anti-feline immunodeficiency virus (fiv) vaccines
ATE283279T1 (de) Therapeutische inhaltsstoffe
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
ATE234861T1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
RU96116005A (ru) Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3
TH23725A (th) วัคซีนป้องกันโรคบิดสำหรับสัตว์ปีก

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING PLOUGH ANIMAL HEALTH CORP., UNION, N.J.,